MedPath

Azithromycin

These highlights do not include all the information needed to use AZITHROMYCIN safely and effectively. See full prescribing information for AZITHROMYCIN. AZITHROMYCIN 250 mg and 500 mg tablets, for oral use AZITHROMYCIN for oral suspension Initial U.S. Approval: 1991

Approved
Approval ID

f7707074-02d4-66a6-e053-6394a90a646a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 21, 2023

Manufacturers
FDA

NuCare Pharmaceuticals,Inc,

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Azithromycin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-2963
Application NumberNDA050710
Product Classification
M
Marketing Category
C73605
G
Generic Name
Azithromycin
Product Specifications
Route of AdministrationORAL
Effective DateMarch 21, 2023
FDA Product Classification

INGREDIENTS (6)

HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
AZITHROMYCIN DIHYDRATEActive
Quantity: 900 mg in 22.5 mL
Code: 5FD1131I7S
Classification: ACTIM
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
SODIUM PHOSPHATE, TRIBASIC, ANHYDROUSInactive
Code: SX01TZO3QZ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Azithromycin - FDA Drug Approval Details